Adverum Biotechnologies Inc (ADVM)

Apr 21, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Adverum Biotechnologies, Inc. (ADVM) Stockholders to Inquire about Securities Investigation - markets.businessinsider.com

Apr 21, 2025

Apr 21, 2025

Truist Removes $40 Price Target on Adverum Biotechnologies, Cites Share Volatility, Keeps Buy Rating - marketscreener.com

Apr 21, 2025

Apr 20, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Adverum Biotechnologies, Inc. (ADVM) Investors to Inquire about Securities Investigation - markets.businessinsider.com

Apr 20, 2025

Apr 18, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Adverum Biotechnologies, Inc. (ADVM) And Encourages Investors to Reach Out - markets.businessinsider.com

Apr 18, 2025

Apr 17, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Adverum Biotechnologies, Inc. (ADVM) And Encourages Stockholders to Reach Out - markets.businessinsider.com

Apr 17, 2025

Apr 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - GlobeNewswire Inc.

Apr 17, 2025

Apr 17, 2025

Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga

Apr 17, 2025

Apr 16, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Adverum Biotechnologies, Inc. (ADVM) And Encourages Stockholders to Connect - markets.businessinsider.com

Apr 16, 2025

Apr 16, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 16, 2025

Apr 16, 2025

RBC Cuts Price Target on Adverum Biotechnologies to $5 From $10, Keeps Sector Perform, Speculative Risk - marketscreener.com

Apr 16, 2025

Apr 15, 2025

Adverum Biotechnologies Reports 2024 Financial Results and Pipeline Progress - TipRanks

Apr 15, 2025

Apr 15, 2025

Adverum Biotechnologies: Q4 Earnings Snapshot - CT Insider

Apr 15, 2025

Apr 15, 2025

Adverum Biotechnologies, Inc. (ADVM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com

Apr 15, 2025

Apr 15, 2025

ADVM Investors Have Opportunity to Join Adverum Biotechnologies, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire

Apr 15, 2025

Apr 15, 2025

Adverum Biotechnologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 15, 2025

Apr 15, 2025

Adverum Biotechnologies Reports Fourth Quarter and Full - GlobeNewswire

Apr 15, 2025

Apr 15, 2025

Adverum Advances Gene Therapy Pipeline Despite Wider Losses: Key Q4 Developments Revealed - Stock Titan

Apr 15, 2025

Apr 15, 2025

Adverum Biotechnologies, Inc. SEC 10-K Report - TradingView

Apr 15, 2025

Apr 14, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc.ADVM - PR Newswire

Apr 14, 2025

Apr 12, 2025

Avalanche Biotechnologies Announces Executive Changes - MarketScreener

Apr 12, 2025

Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 09, 2025

Apr 04, 2025

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 04, 2025

Apr 04, 2025

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 04, 2025

Apr 04, 2025

Adverum Biotech Grants 30,000 Share Options to New Executive: Key Details - Stock Titan

Apr 04, 2025

Apr 03, 2025

Adverum biotechnologies sees $147k stock purchase by major shareholder - Investing.com Australia

Apr 03, 2025

Apr 02, 2025

Adverum Biotechnologies, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsADVM - ACCESS Newswire

Apr 02, 2025

Apr 02, 2025

Adverum Biotechnologies Inc expected to post a loss of $1.36 a shareEarnings Preview - TradingView

Apr 02, 2025

Mar 31, 2025

Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference - The Manila Times

Mar 31, 2025

Mar 31, 2025

Exclusive: Adverum Gene Therapy Updates Coming at Major Ophthalmology Conference - Stock Titan

Mar 31, 2025

Mar 27, 2025

Adverum biotechnologies investor Leonard Braden Michael buys $188,930 in stock By Investing.com - Investing.com Australia

Mar 27, 2025

Mar 20, 2025

Adverum biotechnologies sees insider purchase totaling $587,574 By Investing.com - Investing.com Canada

Mar 20, 2025

Mar 20, 2025

Adverum biotechnologies sees insider purchase totaling $587,574 - Investing.com

Mar 20, 2025

Mar 10, 2025

Adverum Biotechnologies (ADVM) to Release Earnings on Monday - Defense World

Mar 10, 2025

Mar 04, 2025

2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies - GlobeNewswire Inc.

Mar 04, 2025

Mar 03, 2025

Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD - Marketscreener.com

Mar 03, 2025

Mar 03, 2025

Adverum launches phase 3 trial for wet AMD gene therapy By Investing.com - Investing.com UK

Mar 03, 2025

Mar 03, 2025

Can This One-Time Gene Therapy Revolutionize Wet AMD Treatment? Adverum's Phase 3 Trial Begins - StockTitan

Mar 03, 2025

Mar 03, 2025

Adverum Biotechnologies initiates ARTEMIS study - TipRanks

Mar 03, 2025

Mar 01, 2025

Adverum biotechnologies sees $1.44 million stock purchase by major shareholder - Investing.com Australia

Mar 01, 2025

Feb 28, 2025

How Adverum is Attracting Talent: New Employees Receive $186,000 in Equity Grants - StockTitan

Feb 28, 2025